Manufactured for Sciele Pharma, Inc., Atlanta, Georgia 30328 by G. Pohl-Boskamp GmbH & Co. KG, D-25551 Hohenlockstedt, Germany

Scroll down for Important Safety Information.

What is Angina Pectoris?

Angina pectoris is a condition characterized by chest pain that occurs when the muscles of the heart receive an insufficient supply of oxygen. Angina is frequently the first sign of coronary artery disease. Possible angina symptoms include uncomfortable pressure, fullness, squeezing, or pain in the center of the chest. The discomfort also may be felt in the neck, jaw, shoulder, back, or arm. You may experience other symptoms besides those listed here. It is important for you to know what your individual symptoms are so that you can respond quickly.

Fast relief is the key to living with angina pectoris. If you suffer from chest pain or other symptoms associated with angina pectoris, consult with a qualified healthcare professional to find out whether Nitrolingual Pumpspray is right for you. Be sure to read the important safety information and directions for use before beginning treatment with Nitrolingual Pumpspray.

Contact Us for More Information

If you would like more information about Nitrolingual Pumpspray, contact Sciele Pharma, Inc. Nitrolingual Pumpspray is available by prescription only and comes in two convenient sizes – 60- and 200-metered-spray bottles.

Indications and Usage: Nitrolingual Pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.

Important Safety Information: Nitrolingual Pumpspray should not be used while taking phosphodiesterase inhibitors which are used for the treatment of erectile dysfunction. Nitrolingual Pumpspray should be used with caution if patients have low systolic blood pressure, are undergoing diuretic therapy, or show hypersensitivity to this and other nitrates or nitrites. Headache is the most commonly reported side effect with nitroglycerin. Patients may also experience episodes of dizziness, weakness, and other related side effects.

Safety and effectiveness of nitroglycerin in pediatric patients have not been established.

Click here for Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088

Nitrolingual is a registered trademark of G. Pohl-Boskamp GMBH & Co. Sciele's use of Nitrolingual is under license from G. Pohl-Boskamp GMBH & Co.

This web site and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.